A NEW ORALLY-ACTIVE OXYTOCIN ANTAGONIST

被引：0
|
作者：
PETTIBONE, DJ
CLINESCHMIDT, BV
KISHEL, M
LIS, EV
REISS, DR
WOYDEN, CJ
BOCK, MG
CHIU, SHL
EVANS, BE
FREIDINGER, RM
HOBBS, DW
KAUFMAN, MJ
THOMPSON, KL
VEBER, DF
WILLIAMS, PD
COOK, MJ
HALUSKA, GJ
NOVY, MJ
LOWENSOHN, RI
机构：
[1] MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME LTD,W POINT,PA 19486
[3] OREGON REG PRIMATE RES CTR,BEAVERTON,OR 97006
[4] OREGON HLTH SCI UNIV,PORTLAND,OR 97201
来源：
FASEB JOURNAL | 1993年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A478 / A478
页数：1
相关论文
共 50 条
  • [31] THE DISCOVERY OF L-749,329, A HIGHLY POTENT, ORALLY-ACTIVE ANTAGONIST OF ENDOTHELIN RECEPTORS
    WALSH, TF
    FITCH, KJ
    CHAKRAVARTY, PK
    WILLIAMS, DL
    MURPHY, KA
    NOLAN, NA
    OBRIEN, JA
    LIS, EV
    PETTIBONE, DJ
    KIVLIGHN, SD
    GABEL, RA
    ZINGARO, GJ
    KRAUSE, SM
    SIEGL, PKS
    CLINESCHMIDT, BV
    GREENLEE, WJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 145 - MEDI
  • [32] PHARMACOLOGY OF AN ACTIVE METABOLITE OF DUP-753 - AN ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    TIMMERMANS, PBMWM
    WONG, PC
    PRICE, WA
    CHIU, AT
    DUNCIA, JV
    CARINI, DJ
    WEXLER, RR
    JOHNSON, AL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (03) : 699 - 699
  • [33] SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB/IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS
    ZABLOCKI, J
    NICHOLSON, N
    TAITE, B
    PANZERKNODLE, S
    SALYERS, A
    HAAS, N
    SZALONY, J
    FEIGEN, L
    HERIN, M
    JACQMIN, P
    LESNE, M
    BOVY, P
    TJOENG, FS
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1244 - 1244
  • [34] THE PHARMACOLOGY OF SCH-50911 - A NOVEL, ORALLY-ACTIVE GABA-B RECEPTOR ANTAGONIST
    BOLSER, DC
    BLYTHIN, DJ
    CHAPMAN, RW
    EGAN, RW
    HEY, JA
    RIZZO, C
    KUO, SC
    KREUTNER, W
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 274 (03): : 1393 - 1398
  • [35] A NOVEL SERIES OF ORALLY-ACTIVE ANTIPLATELET AGENTS
    ZABLOCKI, JA
    TJOENG, FS
    BOVY, PR
    MIYANO, M
    GARLAND, RB
    WILLIAMS, K
    SCHRETZMAN, L
    ZUPEC, ME
    RICO, JG
    LINDMARK, RJ
    TOTH, MV
    MCMACKINS, DE
    ADAMS, SP
    PANZERKNODLE, SG
    NICHOLSON, NS
    TAITE, BB
    SALYERS, AK
    KING, LW
    CAMPION, JG
    FEIGEN, LP
    BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (05) : 539 - 551
  • [36] ORALLY-ACTIVE PT(IV) ANTITUMOR COMPLEXES
    GIANDOMENICO, CM
    ABRAMS, MJ
    MURRER, BA
    VOLLANO, JF
    HARRAP, KR
    KELLAND, LR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 233 - INOR
  • [37] THIOXYLOSIDE DERIVATIVES AS ORALLY-ACTIVE VENOUS ANTITHROMBOTICS
    BELLAMY, F
    BARBEROUSSE, V
    MARTIN, N
    MASSON, P
    MILLET, J
    SAMRETH, S
    SEPULCHRE, C
    THEVENIAUX, J
    HORTON, D
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 : S101 - S115
  • [38] THE EFFECT ON PLATELETS OF A STABLE ORALLY-ACTIVE IMIDAZOQUINAZOLINE
    TAYLOR, R
    FLEMING, S
    ARNOLD, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (8-9): : 423 - 424
  • [39] VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES
    BUHLMAYER, P
    FURET, P
    CRISCIONE, L
    DEGASPARO, M
    WHITEBREAD, S
    SCHMIDLIN, T
    LATTMANN, R
    WOOD, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) : 29 - 34
  • [40] RS-39604 - A POTENT, SELECTIVE AND ORALLY-ACTIVE 5-HT4 RECEPTOR ANTAGONIST
    HEGDE, SS
    BONHAUS, DW
    JOHNSON, LG
    LEUNG, E
    CLARK, RD
    EGLEN, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) : 1087 - 1095
12345